Results 161 to 170 of about 81,008 (204)

RANKL

2011
  +4 more sources

???????? ????????????????????????????????, RANKL ?? ????????????????????????-17 ?? ???????????????????? ?????????????????? ???????????????? ??????????????????????

2018
?????????????????? ???????????????? ??????????????????????, ?????????????????? ?????????????????????? ???????????????? ?????????? (??????), ?????????????????????????????? ?????????????????????? ?? ???????????????????? ?????????????????????????????? ?????????????? ??????????. ?????????????????????????? ???????????????????????????????? ?????? ????????????
openaire   +1 more source

[Anti-RANKL antibody].

Nihon rinsho. Japanese journal of clinical medicine, 2016
RANKL (receptor activator of nuclear factor-κB ligand) critically regulates the differentiation, activation, and survival of the osteoclast, and the hyperactivation of the RANKL-RANK signaling pathway leads to osteoporosis. Denosumab is a complete human monoclonal antibody against human RANKL, and suppresses bone resorption by inhibiting the ...
Toshinobu, Omiya, Sakae, Tanaka
openaire   +1 more source

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption

Cell, 2021
Weng Hua Khoo, Danyal Butt, Akira Nguyen
exaly  

rankling, adj.

2023
openaire   +1 more source

rankle, n.²

2023
openaire   +1 more source

RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss

EMBO Reports, 2021
Yan Hu, Xiaoqun Li, BiaoTong Huang
exaly  

rankling, n.

2023
openaire   +1 more source

rankled, adj.

2023
openaire   +1 more source

RANKL reverse signaling triggers RANKL translocation via mTORC2 activation

Bone, 2011
M. Honma⁎, A. Hanamura, S. Aoki, Y. Kariya, H. Suzuki   +4 more
openaire   +1 more source